Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic atorvastatin + ezetimibe 40/10 mg vs Atozet in healthy Thai volunteers (fasting)
TCTR20250204001Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of atorvastatin and ezetimibe in hypercholesterolemia and combined dyslipidaemia (2 arms), sponsored by International Bio Service. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
atorvastatinezetimibe
03
Conditions
hypercholesterolemiacombined dyslipidaemia
Beyond the preview
Go deeper on TCTR20250204001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250204001.